The role of IL-6 and STAT3 in inflammation and cancer
Top Cited Papers
- 1 November 2005
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (16), 2502-2512
- https://doi.org/10.1016/j.ejca.2005.08.016
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cellsBiochemical and Biophysical Research Communications, 2004
- The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cellsEuropean Journal of Haematology, 2004
- Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathwaysOncogene, 2003
- Green Tea Polyphenol Causes Differential Oxidative Environments in Tumor versus Normal Epithelial CellsJournal of Pharmacology and Experimental Therapeutics, 2003
- Inflammation and cancerNature, 2002
- Prostaglandin E2 Stimulates Prostatic Intraepithelial Neoplasia Cell Growth through Activation of the Interleukin-6/GP130/STAT-3 Signaling PathwayBiochemical and Biophysical Research Communications, 2002
- Inhibition of Interleukin-6 Signaling and Stat3 Activation by a New Class of Bioactive Cyclopentenone DerivativesBiochemical and Biophysical Research Communications, 2000
- Oxidative Stress Triggers STAT3 Tyrosine Phosphorylation and Nuclear Translocation in Human LymphocytesJournal of Biological Chemistry, 1999
- Inhibition of protein kinase C by retro-inverso pseudosubstrate analoguesBiochemical and Biophysical Research Communications, 1989
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989